Quarry LP’s Drugs Made In America Acquisition Corp Rights DMAAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-249,391
Closed -$15.1K 2616
2026
Q1
$15.1K Buy
249,391
+149,391
+149% +$15.8K ﹤0.01% 850
2025
Q4
$18.7K Hold
100,000
﹤0.01% 1060
2025
Q3
$21.7K Sell
100,000
-50,000
-33% -$9.29K ﹤0.01% 1351
2025
Q2
$18K Hold
150,000
﹤0.01% 1213
2025
Q1
$19.5K Buy
+150,000
New +$21.1K ﹤0.01% 1121

Other funds holding DMAAR

Quarry LP's DMAAR Position: Q2 2026 in Review

Quarry LP sold out of Drugs Made In America Acquisition Corp Rights (DMAAR) in Q2 2026, closing a stake of 249,391 shares — an estimated $15.1K sold.

Quarry LP first reported a position in DMAAR in Q1 2025 and held it in 5 quarters. The position peaked at $21.7K in Q3 2025. 28 funds tracked by Wall St. Rank hold DMAAR as of Q2 2026.

  • Quarry LP reported no remaining Drugs Made In America Acquisition Corp Rights position as of Q2 2026 after selling out during the quarter.
  • Quarry LP sold 249,391 Drugs Made In America Acquisition Corp Rights shares in Q2 2026, an estimated $15.1K.
  • Quarry LP first reported a position in Drugs Made In America Acquisition Corp Rights in Q1 2025 and held it in 5 quarters.
  • Quarry LP's Drugs Made In America Acquisition Corp Rights position peaked at $21.7K in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp Rights as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.